Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | May 7, 2027 (AIDS) | June 5, 2027 (New) | July 5, 2027 (Renewal/Resubmission/Revision) | September 7, 2027 (AIDS) | October 5, 2027 (New) | November 5, 2027 (Renewal/Resubmission/Revision) | January 7, 2028 (AIDS)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports basic science experimental studies involving humans that meet both the NIH definition of a clinical trial and basic research, focusing on fundamental understanding rather than specific applications.
Key Information: Applicants requesting ≥$500,000 in direct costs in any year must contact NIH staff at least 6 weeks before submission.